Nanobiotix S.A. (NBTX) — SEC Filings

Overview

Nanobiotix S.A. (NBTX) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Apr 20, 2026: Nanobiotix S.A. filed a Form 6-K on April 20, 2026, reporting information as a foreign issuer. The filing includes a press release as Exhibit 99.1. The company's mailing and business address is 60 Rue de Wattignies, Paris, France.

Sentiment Summary

Across 50 filings, the sentiment breakdown is: 50 neutral. The dominant filing sentiment for Nanobiotix S.A. is neutral.

Filing Type Overview

Nanobiotix S.A. (NBTX) has filed 49 6-K, 1 20-F with the SEC between Dec 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (50)

• Nanobiotix Files 6-K Report — 6-K · Apr 20, 2026 Risk: low
  Nanobiotix S.A. filed a Form 6-K on April 20, 2026, reporting information as a foreign issuer. The filing includes a press release as Exhibit 99.1. The company'
• Nanobiotix Files 6-K Report with Press Release — 6-K · Mar 30, 2026 Risk: medium
  Nanobiotix S.A. filed a Form 6-K on March 30, 2026, reporting its activities as a foreign issuer. The filing includes a press release as Exhibit 99.1, detailing
• Nanobiotix Files Routine 6-K Report on March 25, 2026 — 6-K · Mar 25, 2026
  This 6-K filing from Nanobiotix S.A. on March 25, 2026, is a routine report by a foreign issuer, indicating no new material financial or operational news. It in
• Nanobiotix Files Routine 6-K Report — 6-K · Dec 17, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on December 17, 2025, reporting its status as a foreign private issuer. The company, incorporated in France with its principal
• 6-K Filing — 6-K · Dec 15, 2025
• Nanobiotix Files 6-K for Managerial Transactions — 6-K · Dec 1, 2025 Risk: low
  On December 1, 2025, Nanobiotix S.A. filed a Form 6-K to disclose transactions by persons discharging managerial responsibilities. This filing serves as a notif
• 6-K Filing — 6-K · Nov 24, 2025
• 6-K Filing — 6-K · Nov 14, 2025
• Nanobiotix Files 6-K for November 2025 — 6-K · Nov 12, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on November 12, 2025, reporting for the month of November 2025. The company, a foreign private issuer, is based in Paris, Franc
• 6-K Filing — 6-K · Nov 3, 2025
• 6-K Filing — 6-K · Oct 31, 2025
• Nanobiotix Files 6-K, Confirms 20-F Reporting — 6-K · Oct 24, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on October 24, 2025, reporting its status as a foreign private issuer. The company, incorporated in France with its principal e
• Nanobiotix Files October 2025 Report (6-K) — 6-K · Oct 15, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on October 15, 2025, to report its activities for the month of October 2025. The company, a pharmaceutical preparations firm, i
• Nanobiotix Files October 2025 6-K Report — 6-K · Oct 1, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on October 1, 2025, reporting for the month of October 2025. The company, a pharmaceutical preparations firm, is based in Paris
• Nanobiotix Files September 2025 6-K Report — 6-K · Sep 30, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on September 30, 2025, for the month of September 2025. The filing is a report of a foreign private issuer and indicates that t
• Nanobiotix Files 6-K with H1 2025 Financials — 6-K · Sep 30, 2025 Risk: medium
  Nanobiotix S.A. filed a 6-K report for the period ending June 30, 2025. The filing includes financial data for the first six months of 2025 and the full year 20
• Nanobiotix Files September 2025 6-K Report — 6-K · Sep 17, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on September 17, 2025, to report its activities for the month of September 2025. The company, based in Paris, France, is a phar
• Nanobiotix Files Routine 6-K Report — 6-K · Sep 12, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on September 12, 2025, to report information for the month of September 2025. The company, based in Paris, France, is a pharmac
• Nanobiotix Files 6-K with SEC — 6-K · Sep 2, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on September 2, 2025, reporting its status as a foreign private issuer. The company, based in Paris, France, is subject to the
• Nanobiotix Files August 2025 6-K Report — 6-K · Aug 27, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on August 27, 2025, reporting its activities for the month of August 2025. The company, a foreign private issuer, is based in P
• Nanobiotix Files July 2025 6-K Report — 6-K · Jul 11, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on July 11, 2025, reporting for the month of July 2025. The company, a foreign private issuer, is based in Paris, France, and o
• Nanobiotix Grants 33,354 Free Shares to HR Director — 6-K · Jul 2, 2025 Risk: low
  On June 27, 2025, Nanobiotix S.A. reported a grant of 33,354 free shares to Anne-Juliette Hermant, the Human Resources Director. This transaction was an initial
• Nanobiotix Files June 2025 Report on Form 6-K — 6-K · Jun 10, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on June 10, 2025, reporting its activities for the month of June 2025. The company, a foreign private issuer, is based in Paris
• Nanobiotix Files Routine 6-K Report — 6-K · May 28, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on May 28, 2025, to report its activities for the month of May 2025. The company, based in Paris, France, is a foreign private
• Nanobiotix Files 6-K on Insider Transactions — 6-K · May 27, 2025 Risk: low
  On May 27, 2025, Nanobiotix S.A. filed a Form 6-K to disclose transactions by persons discharging managerial responsibilities. The filing serves as a notificati
• Nanobiotix Files Routine 6-K Report — 6-K · May 21, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on May 21, 2025, to report its activities for the month of May 2025. The company, based in Paris, France, is a foreign private
• Nanobiotix Discloses Insider Transactions — 6-K · May 15, 2025 Risk: low
  On May 15, 2025, Nanobiotix S.A. filed a Form 6-K to disclose transactions by persons discharging managerial responsibilities. The filing serves as a notificati
• Nanobiotix Files 6-K Report — 6-K · May 14, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on May 14, 2025, reporting its status as a foreign private issuer. The company, based in Paris, France, is registered with the
• Nanobiotix Files Routine 6-K Disclosure — 6-K · May 12, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on May 12, 2025, to report its status as a foreign private issuer filing annual reports under Form 20-F. The filing does not co
• Nanobiotix Files May 2025 Report on Form 6-K — 6-K · May 5, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on May 5, 2025, to report its activities for the month of May 2025. The company, a pharmaceutical preparations firm, is based i
• Nanobiotix Files Routine 6-K Disclosure — 6-K · Apr 30, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on April 30, 2025, reporting its status as a foreign private issuer. The company, incorporated in France with its principal exe
• Nanobiotix Files Routine 6-K Report — 6-K · Apr 14, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on April 14, 2025, reporting its status as a foreign private issuer. The company, incorporated in France with its principal exe
• Nanobiotix Files 6-K on Insider Transactions — 6-K · Apr 14, 2025 Risk: low
  On April 14, 2025, Nanobiotix S.A. filed a Form 6-K to disclose transactions by persons discharging managerial responsibilities. The filing pertains to the mont
• Nanobiotix S.A. Discloses Managerial Transactions — 6-K · Apr 10, 2025 Risk: low
  On April 10, 2025, Nanobiotix S.A. disclosed transactions by individuals in managerial positions. The filing, a Form 6-K, was made for the month of December 202
• Nanobiotix Files April 2025 6-K Report — 6-K · Apr 2, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on April 2, 2025, to report its activities for the month of April 2025. The company, a foreign private issuer, is based in Pari
• 20-F Filing — 20-F · Apr 2, 2025
• Nanobiotix Files March 2025 6-K Report — 6-K · Mar 31, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on March 31, 2025, for the month of March 2025. The company, incorporated in France with its principal executive office in Pari
• Nanobiotix Files March 2025 6-K Report — 6-K · Mar 27, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on March 27, 2025, to report its activities for the month of March 2025. The company, based in Paris, France, is a pharmaceutic
• Nanobiotix Files March 2025 6-K Report — 6-K · Mar 20, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on March 20, 2025, to report its activities for the month of March 2025. The company, based in Paris, France, is a foreign priv
• Nanobiotix Files March 2025 6-K Report — 6-K · Mar 17, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on March 17, 2025, to report its activities for the month of March 2025. The company, based in Paris, France, is a pharmaceutic
• Nanobiotix Files Routine 6-K Report — 6-K · Mar 13, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on March 13, 2025, to report its activities for the month of March 2025. The company, based in Paris, France, is a foreign priv
• Nanobiotix Files February 2025 6-K Report — 6-K · Feb 12, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on February 12, 2025, to report its activities for the month of February 2025. The company, a foreign private issuer, is based
• Nanobiotix Files Routine 6-K Disclosure — 6-K · Jan 29, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on January 29, 2025, to report its status as a foreign private issuer. The company, based in Paris, France, is required to file
• Nanobiotix Files January 2025 6-K Report — 6-K · Jan 21, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on January 21, 2025, reporting for the month of January 2025. The company, based in Paris, France, is a pharmaceutical preparat
• Nanobiotix Files January 2025 6-K Report — 6-K · Jan 10, 2025 Risk: low
  Nanobiotix S.A. filed a Form 6-K on January 10, 2025, for the month of January 2025. The company, headquartered in Paris, France, is a foreign private issuer an
• Nanobiotix Files Form 6-K for December 2024 — 6-K · Dec 17, 2024 Risk: low
  Nanobiotix S.A. filed a Form 6-K on December 17, 2024, to report information for the month of December 2024. The company, based in Paris, France, is a pharmaceu
• Nanobiotix Discloses Insider Transactions — 6-K · Dec 16, 2024 Risk: low
  On December 16, 2024, Nanobiotix S.A. disclosed transactions by individuals in managerial positions. The filing, a Form 6-K, serves as a report of a foreign pri
• Nanobiotix S.A. Reports Managerial Transactions — 6-K · Dec 12, 2024 Risk: low
  On December 12, 2024, Nanobiotix S.A. filed a Form 6-K to report transactions by individuals in managerial positions. The filing is a routine disclosure for for
• Nanobiotix Files Routine 6-K Report — 6-K · Dec 11, 2024 Risk: low
  Nanobiotix S.A. filed a Form 6-K on December 11, 2024, to report information for the month of December 2024. The company, based in Paris, France, is a pharmaceu
• Nanobiotix Files Routine 6-K Report — 6-K · Dec 9, 2024 Risk: low
  Nanobiotix S.A. filed a Form 6-K on December 9, 2024, reporting for the month of December 2024. The company, based in Paris, France, is a foreign private issuer

Frequently Asked Questions